Humulin R Related Published Studies
Well-designed clinical trials related to Humulin R (Insulin Human Subcutaneous)
Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. [2008.10]
Safety and efficacy of inhaled human insulin (Exubera((R))) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial. [2008.09.26]
Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. [2008.09]
Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans. [2008.09]
Acute passive cigarette smoke exposure and inhaled human insulin (Exubera) pharmacokinetics. [2008.06]
Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin. [2008.05]
Effects of smoking cessation, acute re-exposure and nicotine replacement in smokers on AIR inhaled insulin pharmacokinetics and glucodynamics. [2008.04]
The effects of high-intensity intermittent exercise training on fat loss and fasting insulin levels of young women. [2008.04]
Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment. [2008.02]
Effects of Tai Chi on glucose homeostasis and insulin sensitivity in older adults with type 2 diabetes: a randomised double-blind sham-exercise-controlled trial. [2008.01]
Improved insulin sensitivity after a single bout of exercise is curvilinearly related to exercise energy expenditure. [2008.01]
Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients. [2008]
[Impact of weight loss on adipocytokines, C-reactive protein and insulin sensitivity in hypertensive women with central obesity] [2007.12]
[Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen] [2007.11.27]
Heritability and genetic correlations of insulin sensitivity measured by the euglycaemic clamp. [2007.11]
A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in Type 2 diabetes mellitus. [2007.11]
A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients. [2007.10.05]
Effect of lycopene supplementation on insulin-like growth factor-1 and insulin-like growth factor binding protein-3: a double-blind, placebo-controlled trial. [2007.10]
Effects of fasting on insulin action and glucose kinetics in lean and obese men and women. [2007.10]
Behavior of insulin sensitivity and its relation to leptin and tumor necrosis factor-alpha in obese women undergoing liposuction: 6-month follow-up. [2007.09]
Does bicarbonated mineral water rich in sodium change insulin sensitivity of postmenopausal women? [2007.09]
Adding Insulin Glargine Versus Rosiglitazone: Health-related quality-of-life impact in type 2 diabetes. [2007.04]
Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity. [2007.02]
Isolated Isoflavones Do Not Affect the Circulating Insulin-Like Growth Factor System in Men at Increased Colorectal Cancer Risk. [2007.02]
[Effect of high sucrose- and high-fat diets ingested under free-living conditions in insulin resistance in normal weight and overweight women] [2007.01]
Comparative effects of telmisartan and valsartan on insulin resistance in hypertensive patients with metabolic syndrome. [2007]
Effects of simvastatin and metformin on inflammation and insulin resistance in individuals with mild metabolic syndrome. [2007]
A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. [2006.12]
Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia. [2006.11]
Correlations between measures of insulin sensitivity and weight loss. [2006.11]
Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes. [2006.10.11]
Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults. [2006.10]
Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone. [2006.10]
Glycaemic and insulinaemic response of quarter horses to concentrates high in fat and low in soluble carbohydrates. [2006.08]
Accuracy of physical working capacity 170 to estimate aerobic fitness in prepubertal diabetic boys and in 2 insulin dose conditions. [2006.06]
Effects of transdermal testosterone administration on insulin sensitivity, fat mass and distribution, and markers of inflammation and thrombolysis in human immunodeficiency virus-infected women with mild to moderate weight loss. [2006.06]
Smoking enhances absorption of insulin but reduces glucodynamic effects in individuals using the Lilly-Dura inhaled insulin system. [2006.05]
Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. [2006.04]
Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects. [2006.03]
Administration of Lispro insulin with meals improves glycemic control, increases circulating leptin, and suppresses ghrelin, compared with regular/NPH insulin in female patients with type 1 diabetes. [2006.02]
Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients. [2006.01]
Validation of insulin resistance indexes in a stable renal transplant population. [2005.10]
Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients. [2005.08]
Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial. [2005.06]
Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma. [2005.05]
Insulin sensitivity determines the effectiveness of dietary macronutrient composition on weight loss in obese women. [2005.04]
Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy. [2005.04]
Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? [2005.03]
Postprandial insulin response and mitochondrial oxidation in obese men nutritionally treated to lose weight. [2005.03]
Ghrelin response to carbohydrate-enriched breakfast is related to insulin. [2005.02]
A reduced-fat diet and aerobic exercise in Japanese Americans with impaired glucose tolerance decreases intra-abdominal fat and improves insulin sensitivity but not beta-cell function. [2005.02]
[Comparison of pre-dinner regular versus pre-lunch NPH of a third insulin application in adolescents with type 1 diabetes from a Public Health Service] [2004.12]
Inflammation, insulin, and endothelial function in overweight children and adolescents: the role of exercise. [2004.12]
Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone. [2004.12]
Adiponectin, insulin resistance, and C-reactive protein in postpubertal Asian Indian adolescents. [2004.10]
Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients. [2004.09]
Changes in free rather than total insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young healthy adults. [2004.08]
Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. [2004.08]
Well-designed clinical trials possibly related to Humulin R (Insulin Human Subcutaneous)
Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke. [2008.09.23]
Effect of level of dietary n-3 polyunsaturated fatty acid supplementation on systemic and tissue fatty acid concentrations and on selected reproductive variables in cattle. [2008.09.01]
Study protocol--metabolic syndrome, vitamin D and bone status in South Asian women living in Auckland, New Zealand: a randomised, placebo-controlled, double-blind vitamin D intervention. [2008.07.31]
Bolus tube feeding suppresses food intake and circulating ghrelin concentrations in healthy subjects in a short-term placebo-controlled trial. [2008.07]
[Study protocol of the VISEP study : Response of the SepNet study group.] [2008.07]
Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. [2008.07]
Cardiac repolarization during hypoglycaemia in type 1 diabetes: impact of basal renin-angiotensin system activity. [2008.07]
The muscle protein synthetic response to carbohydrate and protein ingestion is not impaired in men with longstanding type 2 diabetes. [2008.06]
Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. [2008.06]
Cost-sparing effect of twice-weekly targeted endurance training in type 2 diabetics: A one-year controlled randomized trial. [2008.06]
Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study. [2008.06]
The effect of high-intensity progressive resistance training on adiposity in children: a randomized controlled trial. [2008.06]
Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. [2008.06]
Effects of GI vs content of cereal fibre of the evening meal on glucose tolerance at a subsequent standardized breakfast. [2008.06]
Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test. [2008.05]
Effects of products made from a high-palmitic acid, trans-free semiliquid fat or a high-oleic acid, low-trans semiliquid fat on the serum lipoprotein profile and on C-reactive protein concentrations in humans. [2008.05]
Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. [2008.04]
Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus. [2008.03]
Improvement of glycaemic control by nateglinide decreases systolic blood pressure in drug-naive patients with type 2 diabetes. [2008.03]
Co-ingestion of leucine with protein does not further augment post-exercise muscle protein synthesis rates in elderly men. [2008.03]
Short- and long-term relationships of serum ghrelin with changes in body composition and the metabolic syndrome in prepubescent obese children following two different weight loss programs. [2008.02.11]
Reduction of proteinuria by rosiglitazone in non-diabetic renal disease. [2008.02]
Effect of weight loss on cytokine messenger RNA expression in peripheral blood mononuclear cells of obese subjects with the metabolic syndrome. [2008.02]
Glucose homeostasis predicts weight gain: prospective and clinical evidence. [2008.02]
Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. [2008.02]
Open-label, randomized, multiple-center, parallel study comparing glycemic responses and safety profiles of Glucerna versus Fresubin in subjects of type 2 diabetes mellitus. [2008.02]
Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene. [2008.01.20]
Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-naive HIV-1-infected patients. [2008.01]
Effects of dietary fibers on weight gain, carbohydrate metabolism, and gastric ghrelin gene expression in mice fed a high-fat diet. [2007.12]
Combination therapy of pioglitazone with voglibose improves glycemic control safely and rapidly in Japanese type 2-diabetic patients on hemodialysis. [2007.11]
Miglitol increases the adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitus. [2007.11]
Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content. [2007.11]
Effect of rosiglitazone on factors related to endothelial dysfunction in patients with type 2 diabetes mellitus. [2007.11]
Influence of carbohydrate, intense exercise, and rest intervals on hormonal and oxidative changes. [2007.10]
Skeletal muscle adaptations to testosterone and resistance training in men with COPD. [2007.10]
Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial. [2007.10]
Effects of weight loss on a low-carbohydrate diet on flow-mediated dilatation, adhesion molecules and adiponectin. [2007.10]
Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. [2007.09]
A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease. [2007.09]
Evidence for distinct effects of GH and IGF-I in the metabolic syndrome. [2007.09]
Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes. [2007.09]
Protein ingestion further augments S6K1 phosphorylation in skeletal muscle following resistance type exercise in males. [2007.08]
Intake of phenol-rich virgin olive oil improves the postprandial prothrombotic profile in hypercholesterolemic patients. [2007.08]
|
